| Literature DB >> 22022641 |
Elizabeth L Tenorio1, Brian A Klein, Wai S Cheung, Linden T Hu.
Abstract
BACKGROUND: Periodontitis is recognized as a complex polymicrobial disease, however, the impact of the bacterial interactions among the 700-1,000 different species of the oral microbiota remains poorly understood. We conducted an in vitro screen for oral bacteria that mitigate selected virulence phenotypes of the important periodontal pathogen, Porphyromonas gingivalis.Entities:
Keywords: bacterial interactions; cytotoxicity; gingipain; oral pathogen; virulence
Year: 2011 PMID: 22022641 PMCID: PMC3198504 DOI: 10.3402/jom.v3i0.8396
Source DB: PubMed Journal: J Oral Microbiol ISSN: 2000-2297 Impact factor: 5.474
Inhibition of Porphyromonas gingivalis (Pg) cytotoxicity by clinical strains
| Inhibition of | ||||
|---|---|---|---|---|
| Classification of clinical isolates | Number of strains | − | + | ++ |
| Actinobacteria (Gram+, high G+C ratio) | ||||
| 13 | 5 | 4 | 4 | |
| 2 | 1 | 0 | 1 | |
| 1 | 1 | 0 | 0 | |
| 3 | 0 | 2 | 1 | |
| Firmicutes (Gram+, low G+C ratio) | ||||
| 1 | 1 | 0 | 0 | |
| 1 | 1 | 0 | 0 | |
| 2 | 2 | 0 | 0 | |
| 2 | 2 | 0 | 0 | |
| 2 | 2 | 0 | 0 | |
| 3 | 2 | 0 | 1 | |
| 1 | 1 | 0 | 0 | |
| 2 | 2 | 0 | 0 | |
| 3 | 2 | 1 | 0 | |
| 2 | 2 | 0 | 0 | |
| 5 | 3 | 0 | 2 | |
| 1 | 1 | 0 | 0 | |
| 13 | 12 | 0 | 1 | |
| 2 | 2 | 0 | 0 | |
| 3 | 3 | 0 | 0 | |
| 17 | 16 | 0 | 1 | |
| 3 | 3 | 0 | 0 | |
| Fusobacteria (Gram–) | ||||
| 1 | 1 | 0 | 0 | |
| 1 | 1 | 0 | 0 | |
| Veillonella (Gram–) | ||||
| 2 | 2 | 0 | 0 | |
| 2 | 1 | 0 | 1 | |
| Unidentified oral isolates | 15 | 15 | 0 | 0 |
| Total | 103 | 84 | 7 | 12 |
Inhibition of Pg cytotoxicity was evaluated using an in vitro cell-rounding assay. OKF6/Tert-2 cells exposed for 16 hrs to Pg (MOI=100) showed complete rounding and detachment upon microscopic observation. The effects of coincubation with isolates on Pg cytotoxicity were scored as follows: ‘–’ no visible inhibition (complete cell rounding and detachment), ‘+’ weak inhibition (partial cell rounding and detachment), and ‘++’ strong inhibition (minimal cell rounding and detachment). The table describes the number of isolates within each species of bacteria that inhibited P. gingivalis cytotoxicity. The assay was performed in duplicate and confirmed in at least two independent experiments. A total of 103 clinical strains were analyzed.
Fig. 1Effects of Porphyromonas gingivalis (Pg) on oral epithelial cells. (A) Pg W83, Streptococcus oralis 180B (So180B), or Pg+So180B were added to OKF6/TERT2 cells. Cocultures were allowed to incubate in 5% CO2 at 37°C for 16 hr and then examined by blinded investigators. (B) OKF6/TERT-2 cells were grown to confluence and used in the wound-healing assay. A linear streak was made in the cell monolayer. Pg, So180B, or Pg+So180B were added to the cultures at MOI=100. After incubation for 2 hrs, the plates were washed to remove bacteria and fresh media was added. The cultures were incubated for 16 hrs and read by blinded investigators.
Effects on Porphyromonas gingivalis (Pg) gingipain activity and production of acid and hydrogen peroxide by oral bacterial strain
| Percent change in gingipain activity | Production of | |||||||
|---|---|---|---|---|---|---|---|---|
| Cocultured with | Independent culture | Acid (pH) | H2O2 (ng/ml) | |||||
| Clinical isolates | % | % | ||||||
| 9 | Ns | −24 | Ns | 6 | 476 | |||
| −12 | Ns | −9 | Ns | 5.8 | – | |||
| 14 | Ns | −27 | 0.002 | 5.8 | – | |||
| 0 | Ns | 17 | Ns | 5.8 | – | |||
| 2 | Ns | −8 | Ns | 5.8 | – | |||
| 7 | Ns | 14 | Ns | 5.8 | – | |||
| 9 | Ns | 1 | Ns | 5.8 | – | |||
| 4 | Ns | −31 | 0.003 | 6.4 | 1,547 | |||
| 13 | Ns | −10 | Ns | 7 | – | |||
| 4 | Ns | −2 | Ns | 7 | – | |||
| −2 | Ns | −31 | 0.009 | 5.8 | – | |||
| −28 | 0.001 | −9 | Ns | 7 | – | |||
| −35 | 0.009 | 14 | Ns | 7 | – | |||
| 5 | Ns | 7 | Ns | 5.5 | – | |||
| −36 | 0.006 | −35 | 0.002 | 6.2 | 759 | |||
| 10 | Ns | −34 | 0.001 | 7 | 654 | |||
| 4 | Ns | −26 | 0.003 | 6.2 | 652 | |||
| −55 | 0.005 | −18 | Ns | 6.6 | – | |||
| −27 | 0.001 | −8 | Ns | 6.2 | – | |||
Porphyromonas gingivalis (Pg) total gingipain activity was assayed by incubating Pg and each of 19 oral bacterial strains (identified in Table 1 as inhibitory to Pg cytotoxicity) with BANA substrate and observing the change in color upon the addition of Fast Blue BB detection solution. The oral bacteria were either cocultured with P. gingivalis for 1 day or cultured independently and mixed with Pg immediately prior to the assay. The OD490nm of the reaction mixtures was measured and expressed as percent activity compared to Pg alone. Statistically significant (P>0.01) effects of clinical isolates on gingipain activity compared to Pg alone when analyzed using a paired t-test are indicated in bold type. Ns=nonsignificant. Acid production by inhibitory clinical isolates was assayed by measuring the pH of TS broth cultures after 48 hrs at 37°C. The presence of H2O2 in broth cultures after 48 hrs was measured using Hydrogen Peroxide Assay Kit as described in Methods. Data shown are the means of three experiments in triplicate. Samples below the level of detection of 15 ng/ml are marked as ‘–’.
Less than 98% 16S rRNA sequence similarity to the closest type strain.
Fig. 2Effect of oral bacterial isolates on Porphyromonas gingivalis (Pg) growth. Broth cultures of 19 clinical strains identified as inhibitory to Pg cytotoxicity were spotted on blood agar inoculated with a lawn of Pg and incubated anaerobically at 37°C for 48 hrs. The growth of Pg was inhibited near the colonies of 6 of 19 strains including (A) Streptococcus intermedius and Actinomyces naeslundii. (B) Growth inhibition was measured as the size of the clear zone (in mm) between the edge of the colony and the lawn of P. gingivalis. Bars represent the average of triplicate measurements confirmed in three independent experiments. Abbreviations used: An, Actinomyces naeslundii; Pa, Propionibacterium acnes; Si, Streptococcus intermedius; Smi, Streptococcus mitis; Sc, Streptococcus constellatus; So, Streptococcus oralis; Streptococcus sanguinis; Vd, Veillonella dispar. *less than 98% 16S rRNA sequence similarity to the closest type strain.